Healthcare – Senators unveil bipartisan insulin bill

If you’ve ever wanted to sell clothes with “THE” plastered on them, then you’re out of luck because The Ohio State University now has a brand on the word.

Today in health care there is a new bipartisan bill to cut insulin costs, but it faces a tough pass.

Welcome to night health care, where we follow the latest developments in policies and news concerning your health. For The Hill, we are Peter Sullivan, Nathaniel Weixel and Joseph Choi. Did someone forward this newsletter to you? Subscribe here.

Shaheen and Collins roll out bipartisan insulin bill’

Meaning. Jeanne Shaheen (DN.H.) and Susan Collins (R-Maine) legislation unveiled Wednesday aimed at lowering the cost of insulin, seeking a bipartisan breakthrough on one of the most high-profile examples of patient-defying high drug prices.

The legislation would cap patients’ insulin spending at $35 per month and include provisions to incentivize drugmakers to reduce the overall price of insulin.

“For too long, patients have stretched their budgets, rationed insulin, and made difficult personal decisions to keep this drug close at hand for themselves or loved ones,” Shaheen and Collins said in a statement. joint statement.

Hard way to go: The measure faces a steep path to pass the Senate, however. In addition to Collins, nine other Republicans would need to support the bill to cross a 60-vote threshold. Only 12 House Republicans voted for the House version of the insulin legislation in March, with a certain calling the bill “price controls”.

Vote soon: Senate Majority Leader Charles Schumer (DN.Y.) said Wednesday he would put the legislation to a vote “very soon” and pressure Republicans to support it.

“At least one in four insulin users report rationing their use because they can’t afford it, putting their health and life at risk,” Schumer said. “Senators Shaheen and Collins’ bipartisan legislation deserves the support of anyone who claims to want to cut costs for the American people.”

Learn more here.

Advocates cautiously optimistic on Juul ban report

Tobacco control advocates said they were cautiously optimistic following a report that the Food and Drug Administration (FDA) is preparing to pull Juul’s vaping products from shelves.

The FDA move, as reported by The Wall Street Journal, would end a two-year review of the company’s application to sell tobacco-menthol flavored e-cigarettes.

  • Erika Sward, National Assistant Vice President of Advocacy for the American Lung Association: If the report is true, “it’s welcome and long overdue.”
  • Matt Myers, president of Campaign for Tobacco Free Kids: “If these reports are accurate, this would be the most significant action the FDA has taken to date to end the e-cigarette epidemic among young people.”

An FDA spokeswoman said the agency had no information to share and no decision has been publicly announced.

Past: In 2020, the FDA required all e-cigarette and vaping companies to submit applications to continue to market products. Since then, the agency has been reviewing manufacturers’ applications.

The agency also banned the sale of all vaping flavors except tobacco and nicotine and did not license any companies to legally sell flavors.

Learn more here.


Nearly a third of registered voters said in a new poll that their state would be less desirable to live in if it banned abortion.

  • The USA Today-Suffolk Poll found that 6 in 10 voters said a state abortion ban would not affect their thinking about its desirability, 31% said it would make the state less desirable, and 5% said that it would be more desirable.
  • The proportion of those who said an abortion ban would make their condition less desirable was higher for respondents aged 18 to 25 – 42% – and those with a university degree.

The poll comes as the Supreme Court prepares to rule on Dobbs v. Jackson Women’s Health Organization, a dispute over a Mississippi state law that would ban most abortions after 15 weeks of pregnancy.

A draft opinion written by Judge Samuel Alito on the case was leaked in May, showing that a majority of justices were set to overturn the landmark Roe v. Wade who protected the right to abortion at the federal level.

The Supreme Court is in the final weeks of its term with 13 rulings remaining, and the court is expected to issue additional rulings on Thursday.

Learn more here.


New data collected by the US government has revealed that nearly one in five adults who previously had COVID-19 now report having symptoms of long COVID.

  • The information was obtained via the “Household surveyconducted by the Census Bureau and the National Center for Health Statistics (NCHS). The NCHS began asking about the presence of long COVIDs in early June.
  • Early research on how quickly long COVID occurs has been varied, with some estimates indicating that a majority of people infected with COVID experience the puzzling condition while others have found that only a small minority experience the corresponding symptoms. .

Of more than 62,000 adults surveyed, 40% said they had already had a COVID-19 infection. Of this group, 19% said they are currently experiencing symptoms of long COVID.

Overall, 14% of adults with previous infections reported having had post-COVID symptoms at some point.

In the general population, one in 13 or 7.5% American adults reported having long COVID symptoms that lasted three months or more after their initial infection.

Learn more here.

House panel condemns influence of Trump adviser

A report released by the House Select Subcommittee on the Coronavirus Crisis rebuked this doctor’s influence Scott Atlas had in the Trump administration during his tenure as pandemic adviser and accused him of undermining the government’s efforts to fight COVID-19.

  • During his time working with the Trump administration, Atlas frequently sparked controversy over his promotion of practices that apparently contradicted pandemic mitigation methods recommended by other federal government health officials.
  • The subcommittee’s report, titled “The Atlas Dogma,” listed numerous instances in which the Trump administration took what the panel called “dangerous and discredited” approaches to handling the pandemic, including the strategy of herd immunity of which Atlas is a proponent.

Atlas has been regularly accused of seeking to downplay the severity of the pandemic, calling the government’s early response to COVID-19 an “overreaction”. He frequently criticized mask-wearing and social distancing and often mocked other health authorities and politicians who encouraged these practices.

Atlas’ influence on the Trump administration appears to have begun before he was appointed adviser, according to the report, with the panel saying his involvement was covered up for several weeks after he was hired.

Learn more here.


  • The unintended consequences of the $178 billion bailout to keep hospitals and doctors afloat (Washington Post)
  • COVID vaccines are finally here for young children. But the logistics is not easy (NPR)
  • Years after the Brigham-Harvard scandal, the United States is pouring millions into the field of contaminated stem cells (Reuters)
  • 100 million adults have healthcare debt – and 12% of them owe $10,000 or more (CNBC)


  • Tennessee House GOP urges Governor Lee to block state distribution of COVID vaccine for younger children (tennessian)
  • SC law allows health care providers to deny elective care based on beliefs (NPR)
  • State health department fires employee for reference to abortion drug in newsletter (Ohio Capital Journal)


That’s all for today, thanks for reading. Discover The Hill’s Healthcare page for the latest news and coverage. Until tomorrow.


Leave a Comment